T 0248/05 (Particulate direct label/INVERNESS) of 25.04.2006
- European Case Law Identifier
- ECLI:EP:BA:2006:T024805.20060425
- Date of decision
- 25 April 2006
- Case number
- T 0248/05
- Petition for review of
- -
- Application number
- 93108764.7
- IPC class
- G01N 33/52
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Specific binding assays
- Applicant name
- Inverness Medical Switzerland GmbH
- Opponent name
- 1. ulti med Products (Deutschland)
2. VEDA LAB
3. Cardimac Gesellschaft für Diagnostische Schnellteste mbH
4. Opfermann Arzneimittel GmbH
5. Adexpert GmbH
6. Acon Laboratories
7. Biomar Diagnostic Systems GmbH
8. Quidel Deutschland GmbH
9. QUIDEL CORPORATION
10. Progen Biotechnik - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104(1) 1973European Patent Convention Art 123(2) 1973
- Keywords
- Main request - added subject-matter (no)
Apportionment of costs (no)
Remittal to the first instance (yes) - Catchword
- -
- Cited cases
- G 0001/03
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The intervention of intervener 05, Adexpert GmbH, is admissible.
2. The decision under appeal is set aside.
3. The case is remitted to the opposition division for further prosecution on the basis of the appellant's main request (claims as granted) submitted with the statement setting out the grounds of appeal dated 12 May 2005.
4. The request for appointment of its appeal costs filed by intervener 05, Adexpert GmbH, is rejected.